| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Elicio Therapeutics, Inc.
13D/A
ELTX · 28657F103
|
48.1% |
3/7/2025
Event 3/5/2025
|
||||
| Yekaterina Chudnovsky | 48.1% | |||||
| GKCC, LLC | 48.0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.